Sol J. Barer

About

Portfolio · 1

MediWound

Enzymatic Therapeutics for Non-Surgical Tissue Repair

1 round $8.0M committed Latest: 2023-02

Investment activity

Q&A

What is Sol J. Barer's primary investment focus?

Sol J. Barer is an angel investor primarily focused on the Biotech sector, as indicated by his background as a former Chairman of Teva pharmaceuticals and his investment in Health Tech & Life Sciences.

Can you name a notable portfolio company of Sol J. Barer?

One notable portfolio company of Sol J. Barer is MediWound, which develops enzymatic therapeutics for non-surgical tissue repair.

What is Sol J. Barer's investment activity in terms of funding stages?

Sol J. Barer has participated in PIPE funding rounds.

When was Sol J. Barer's most recent investment activity recorded?

Sol J. Barer's most recent investment activity was recorded in February 2023.

What is the typical investment range for Sol J. Barer?

Sol J. Barer's investment range is between $8.03M and $8.03M.

What is Sol J. Barer's role in the investment landscape?

Sol J. Barer operates as an angel investor, with a focus on early-stage and growth companies in the biotech and life sciences sectors.